Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Shanghai MicroPort MedBot (Group) Co (HKSE:02252) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Shanghai MicroPort MedBot (Group) Co's EV-to-EBIT for today is
Shanghai MicroPort MedBot (Group) Co's current Enterprise Value is HK$26,045.2 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Shanghai MicroPort MedBot (Group) Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-257.8 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Shanghai MicroPort MedBot (Group) Co's EV-to-EBITDA for today is:
Shanghai MicroPort MedBot (Group) Co's current Enterprise Value is HK$26,045.2 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Shanghai MicroPort MedBot (Group) Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-257.8 Mil.
Shanghai MicroPort MedBot (Group) Co's current Enterprise Value is HK$26,045.2 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Shanghai MicroPort MedBot (Group) Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was HK$606.7 Mil.
Shanghai MicroPort MedBot (Group) Co's current Enterprise Value is HK$26,045.2 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Shanghai MicroPort MedBot (Group) Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-23.8 Mil.
Shanghai MicroPort MedBot (Group) Co's current Enterprise Value is HK$26,045.2 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Shanghai MicroPort MedBot (Group) Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-26.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai MicroPort MedBot (Group) Co Enterprise Value Related Terms
Shanghai MicroPort MedBot (Group) Co Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai MicroPort MedBot (Group) Co Enterprise Value Chart
HKSE:02252 vs ABT, SYK, MDT: Enterprise Value Comparison
For the Medical Devices subindustry, Shanghai MicroPort MedBot (Group) Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai MicroPort MedBot (Group) Co Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai MicroPort MedBot (Group) Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Shanghai MicroPort MedBot (Group) Co's Enterprise Value falls into.
Shanghai MicroPort MedBot (Group) Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of HK$26,045.2 Mil mean?
Shanghai MicroPort MedBot (Group) Co (HKSE:02252) has a Enterprise Value of HK$26,045.2 Mil as of Aug. 14, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Shanghai MicroPort MedBot (Group) Co and its competitors.
Is Shanghai MicroPort MedBot (Group) Co's Enterprise Value too high?
Shanghai MicroPort MedBot (Group) Co's current Enterprise Value is HK$26,045.2 Mil. Overall, Shanghai MicroPort MedBot (Group) Co has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shanghai MicroPort MedBot (Group) Co's Enterprise Value compare to ABT and SYK?
Shanghai MicroPort MedBot (Group) Co's Enterprise Value of HK$26,045.2 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Shanghai MicroPort MedBot (Group) Co and its competitors. Shanghai MicroPort MedBot (Group) Co's current Enterprise Value is HK$26,045.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai MicroPort MedBot (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai MicroPort MedBot (Group) Co (HKSE:02252) is currently considered Possible Value Trap. The stock's GF Value™ is HK$81.81, compared to a current price of HK$25.48 — trading 68.9% below its estimated fair value. The current Enterprise Value is HK$26,045.2 Mil. Shanghai MicroPort MedBot (Group) Co's overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Shanghai MicroPort MedBot (Group) Co (HKSE:02252), the current Enterprise Value is HK$26,045.2 Mil as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai MicroPort MedBot (Group) Co (HKSE:02252) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai MicroPort MedBot (Group) Co stock appears to be undervalued.
The current stock price of HK$25.48 is trading 68.9% below its estimated GF Value™ of HK$81.81.
GuruFocus considers Shanghai MicroPort MedBot (Group) Co to be Possible Value Trap.
Key valuation signals for HKSE:02252:
Enterprise Value: HK$26,045.2 Mil
GF Value™: HK$81.81 vs. price of HK$25.48 (68.9% below fair value)
No single metric tells the full story. See the HKSE:02252 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai MicroPort MedBot (Group) Co Ltd is a surgical robot company dedicated to designing, developing, and commercializing surgical robots to assist surgeons in performing complex surgical procedures. The business of the company covers various surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice, and percutaneous surgical procedures, and has accumulated several products at various stages as those in development, clinical trials, registration, and commercialisation. The company derives revenue principally from the sales of surgical robot systems, instruments, and accessories, and the provision of services through appointed distributors. Geographically, it derives maximum revenue from the People's Republic of China.
45GF Score
Get the complete analysis for HKSE:02252
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02252 has been successfully added to your 
